In 2025, Archer Aviation achieved its most credible execution milestones to date, advancing its Midnight eVTOL program from concept to operational testing. The company completed over 150 tethered and free-flight tests across three prototype aircraft, validating key systems such as autonomous flight controls and battery thermal management. In Q2, Archer initiated low-rate production at its San Jose facility, producing five flight‐worthy airframes and establishing an assembly line capable of handling up to 12 units per quarter once fully scaled.

During the year, Archer bolstered its capital base, closing the third quarter with in excess of $2.0 billion in cash and equivalents following a $500 million private placement in July. This liquidity contrasts sharply with peers burning through capital without securing fresh funding. Despite an annual cash burn of approximately $300 million—primarily driven by R&D and certification activities—the company’s balance sheet now supports ongoing FAA engagement and manufacturing investments through late 2026, reducing the immediate threat of dilution.

Archer’s Launch Edition initiative in the United Arab Emirates progressed rapidly in 2025, with six demonstration flights conducted in Abu Dhabi under a regulatory sandbox framework. Collaborative agreements with two regional airlines envision initial passenger service routes by 2027, contingent on type certification. This global push offers a parallel path to revenue generation and brand credibility, potentially providing operational leverage if U.S. certification timelines slip beyond current forecasts.

Despite clear advances, Archer faces significant execution challenges over the next 12–24 months. The company must secure full FAA type certification—a process that typically spans 24–36 months from preliminary reviews—while scaling production from single‐digit prototypes to an industrialized output. Concurrently, competitors further along in the approval process, such as Joby Aviation, threaten to capture early-market share. Investors should weigh Archer’s strengthened balance sheet and international momentum against the unproven nature of its manufacturing pipeline and the potential for regulatory delays.